| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/03/2004 | US6770800 Modulating chromosomal duplication in plants; obtain cells, transform with expression vector containing replicase, monitor replication in cells |
| 08/03/2004 | US6770799 For therapy of victim of acetylcholinesterase poisoning |
| 08/03/2004 | US6770747 Introducing this gene into plants that do not have said gene stabilizes a yellow pigment aurone and plants having yellow flowers can be obtained |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770481 A plasmid vector usable in genetic recombinant technology and a method for expressing a gene by using the plasmid vector; isolating a desired gene by using such a plasmid vector |
| 08/03/2004 | US6770473 Wild-type and mutant human kinase interacting strathmin (hkis) polypeptides along with cyclin kinase inhibitors containing mutations that prevent their inhibition with serine/ threonine kinases |
| 08/03/2004 | US6770469 Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof |
| 08/03/2004 | US6770468 Nucleotide and amino sequences of the lysosomal targeting pathway enzyme phosphodiester alpha - glcnacase, methods of producing and methods of purifying this enzyme |
| 08/03/2004 | US6770467 Screening method for ligands with class II P13 kinase modulating activity |
| 08/03/2004 | US6770466 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 08/03/2004 | US6770465 Dna sequences used for expression of the engineered beta-ketoacyl-acp synthases in host cells, particularly seed cells of oilseed crop plants, for the modification of fatty acid composition. |
| 08/03/2004 | US6770464 Synthesis and isolation of polylactone polyester biopolymers from recombinant bacteria comprising fragment of poly (hydroxy fatty acid) synthase from thiocapsa incubated with carbon source |
| 08/03/2004 | US6770460 Fusion protein having epitopes of at least two of the autoantigens glutamic acid decarboxylase (gad65), islet cell antigen (ia2) and preproinsulin (ppins) wherenin said epitopes are connected with a linker peptide |
| 08/03/2004 | US6770457 Process of purifying angiogenesis inhibitors |
| 08/03/2004 | US6770452 Identification of herbicides by measuring the activity of an serine acetyltransferase (sat) in the presence and absence of a compound, an alteration of sat activity in the presence of the compound indicates the compound as a possible herbicide |
| 08/03/2004 | US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor |
| 08/03/2004 | US6770277 Recombinant DNase B derived from streptococcus pyogenes |
| 08/03/2004 | CA2454572A1 Crystalline pde4d2 catalytic domain complex, and methods for making and employing same |
| 08/03/2004 | CA2362367C Telomerase reverse transcriptase transcriptional regulatory sequences |
| 08/03/2004 | CA2149321C Method for stabilizing rice bran and rice bran products |
| 07/29/2004 | WO2004063715A2 Methods of using crystal structure of carboxyltransferase domain of acetyl-coa carboxylase, modulators thereof, and computer methods |
| 07/29/2004 | WO2004063385A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-METHYLCYSTEINE DERIVATIVE |
| 07/29/2004 | WO2004063369A1 Gene sequence of l-rhamnose isomerase having new catalytic function and use thereof |
| 07/29/2004 | WO2004063367A1 Process for inhibiting enzymatic activity |
| 07/29/2004 | WO2004063360A2 Improved method for the production of vitamin b12 |
| 07/29/2004 | WO2004063357A1 Methods for preserving and/or storing cells having a nitrilase or nitrile hydratase activity |
| 07/29/2004 | WO2004063355A2 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| 07/29/2004 | WO2004063349A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063346A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063344A2 CATALYTIC DOMAINS OF β/1,4)-GALACTOSYLTRANSFERASE I HAVING ALTERED DONOR AND ACCEPTOR SPECIFICITIES, DOMAINS THAT PROMOTE IN VITRO PROTEIN FOLDING, AND METHODS FOR THEIR USE |
| 07/29/2004 | WO2004063328A2 Method for cloning and expression of bsrgi restriction endonuclease and bsrgi methyltransferase in e. coli |
| 07/29/2004 | WO2004062627A2 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 07/29/2004 | WO2004062618A2 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062581A2 Structural models of carnitine acyltransferases and uses thereof |
| 07/29/2004 | WO2004062365A2 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 07/29/2004 | WO2004062351A2 Gene encoding resistance to acetolactate synthase-inhibiting herbicides |
| 07/29/2004 | WO2004062350A2 Methods and compositions for producing male sterile plants |
| 07/29/2004 | WO2004053039A3 Detergent composition comprising endo-glucanase |
| 07/29/2004 | WO2004038026A3 Calcineurin-like human phosphoesterase |
| 07/29/2004 | WO2004026285A3 Compositions and methods for treating heart disease |
| 07/29/2004 | WO2004020627A3 Improved dna and proteins |
| 07/29/2004 | WO2004015088A3 Transposon-based transformation system |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2004013322A3 Degrading lignocellulosic materials |
| 07/29/2004 | WO2004011671A3 Diacylglycerol acyltransferase nucleic acid sequences and associated products |
| 07/29/2004 | WO2004009761A3 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 07/29/2004 | WO2003103578A3 Bacteriophage and enzymes lytic to salmonellae |
| 07/29/2004 | WO2003102148A3 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003060476A3 Modulation of cop9 signalsome isopeptidase activity |
| 07/29/2004 | WO2003060110A3 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/29/2004 | WO2003060067A3 P85-alpha nucleic acids, polypeptides and related methods |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003054177A3 New glycosyl hydrolases |
| 07/29/2004 | WO2003054155A3 Pichia pastoris formate dehydrogenase and uses therefor |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003024974A3 Process for preparing protease inhibitor intermediates |
| 07/29/2004 | US20040148658 Phosphatase stress-related proteins and methods of use in plants |
| 07/29/2004 | US20040148657 Expression of recombinant human acetylcholinesterase in transgenic plants |
| 07/29/2004 | US20040148655 of a brassinosteroids (BRs) biosynthetic locus, designated dwarfs (dwf5), each of which contain loss-of-function mutations in the sterol Delta 7 reductase gene; in vivo/vitro cultures |
| 07/29/2004 | US20040148653 Triacylglycerol lipases |
| 07/29/2004 | US20040148651 Maize glutamine synthetase gene promoter |
| 07/29/2004 | US20040148650 herbicide resistant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Eleusine indica; genetic engineering |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040148149 Molecular modeling for metalloproteins |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147011 High growth methanotrophic bacterial strain |
| 07/29/2004 | US20040147009 Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| 07/29/2004 | US20040147008 Subtilase variants |
| 07/29/2004 | US20040147007 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/29/2004 | US20040147006 Amino acid sequences comprising nuclear localization signal petides for use as enzyme inhibitors in treatment of viral and nervous system disorders; gene therapy and mimetics |
| 07/29/2004 | US20040147005 Lipolytic hydrolase for releasing oleoresin for use in fragrances, flavour, perfumes, colorants and foods; detergents |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040147002 Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds |
| 07/29/2004 | US20040147001 Use of cloud-point extraction |
| 07/29/2004 | US20040146999 Transformed yeast strains and their use for the production of monoterminal and diterminal aliphatic carboxylates |
| 07/29/2004 | US20040146998 polyester synthesis-associated gene which functions and can be expressed with good efficiency in a yeast |
| 07/29/2004 | US20040146997 using bacterium grown in the presence of lysine or deregulated for lysine biosynthesis; genetic engineering |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146984 Comprises endopeptidase for use as tool in identifying modulators which prevent bacterial infection; enzyme inhibitors |
| 07/29/2004 | US20040146982 hKIS compositions and methods of use |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146980 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146962 Isolated human protease proteins, nucleic acid molecules encoding human protese proteins, and uses thereof |
| 07/29/2004 | US20040146960 Methods for the identification of inhibitors of Trehalose-6-Phosphate Synthase as antibiotics |
| 07/29/2004 | US20040146955 CA IX-specific inhibitors |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146947 Inflammatory bowel disease: noninvasive diagnosis |
| 07/29/2004 | US20040146942 for drug screening in vivo/vitro gene therapy for inflammatory/persistent pain; animal models; genetic engineering |
| 07/29/2004 | US20040146939 for drug screening using animal models for regulating one or more proteins involved in growth, proliferation, and metabolism; solid phase synthesis; genetic engineering |
| 07/29/2004 | US20040146938 Methods of generating and screening for proteases with altered specificity |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146924 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/29/2004 | US20040146904 Vascular-preferred promoter sequences and uses thereof |